Skip to main content
Log in

LC–MS–MS Development and Validation for Simultaneous Quantitation of Metformin, Glimepiride and Pioglitazone in Human Plasma and Its Application to a Bioequivalence Study

  • Original
  • Published:
Chromatographia Aims and scope Submit manuscript

Abstract

A simple, precise and reproducible liquid chromatography–tandem mass spectrometry method has been developed and validated according to the Food and Drug Administration guidelines for the simultaneous quantitation of antidiabetic drugs metformin, glimiperide and pioglitazone in human plasma using glipizide as an internal standard. Quantitation was performed on a triple quadrupole mass spectrometer employing electrospray ionization technique, operating in multiple reaction monitoring and positive ion mode. Inter-batch and intra-batch coefficient of variation across four validation runs for the quality control samples was less than 7%. The accuracy determined at quality control levels was within 92.81–105.13%. The method was applied to a bioequivalence study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. DeFronzo RA (1997) Diabetes 4:177–269

    Google Scholar 

  2. Reaven GM (1988) Diabetes 37:595–607

    Google Scholar 

  3. Lillioja S, Mott DM, Howard BV, Bennett PH, Yki-Jarvinen H, Freymond D, Nyomba BL, Zurlo F, Swinburn B, Bogardus C (1988) N Engl J Med 318:1217–1225

    CAS  Google Scholar 

  4. Prospective Diabetes Study Group (1998) Lancet 352:837–853. doi:10.1016/S0140-6736(98)07019-6

    Article  Google Scholar 

  5. Bennett PH (1989) Lancet 1:1356–1359

    Google Scholar 

  6. Bonora E, Targher G, Alberiche M, Formentini G, Calcaterra F, Lombardi S, Marini F, Poli M, Zenari L, Raffaelli A, Perbellini S, Zenere MB, Saggiani F, Bonadonna RC, Muggeo M (2002) Diabet Med 19:535–542. doi:10.1046/j.1464-5491.2002.00764.x

    Article  CAS  Google Scholar 

  7. Turner RC, Cull CA, Frighi V, Holman RR (1999) JAMA 281:2005–2012. doi:10.1001/jama.281.21.2005

    Article  CAS  Google Scholar 

  8. DeFronzo RA (1999) Ann Int Med 131:281–303

    CAS  Google Scholar 

  9. Spiegelman BM (1998) Diabetes 47:507–514. doi:10.2337/diabetes.47.4.507

    Article  CAS  Google Scholar 

  10. Hofmann C, Lorenz K, Colca JR (1991) Endocrinology 129:1915–1925

    Article  CAS  Google Scholar 

  11. Kemnitz JW, Elson DF, Roecker EB, Baum ST, Bergman RN, Meglasson MD (1994) Diabetes 43:204–211. doi:10.2337/diabetes.43.2.204

    Article  CAS  Google Scholar 

  12. Spiegelman BM (1998) Diabetes 47:507–514. doi:10.2337/diabetes.47.4.507

    Article  CAS  Google Scholar 

  13. Miyazaki Y, Mahankali A, Matsuda M, Glass L, Mahankali S, Ferrannini E, Cusi K, Mandarino LJ, DeFronzo RA (2001) Diabetes Care 24:710–719. doi:10.2337/diacare.24.4.710

    Article  CAS  Google Scholar 

  14. Lenhard JM, Kliewer SA, Paulik MA, Plunket KD, Lehmann JM, Weiel JE (1997) Biochem Pharmacol 54:801–808. doi:10.1016/S0006-2952(97)00229-3

    Article  CAS  Google Scholar 

  15. Rosenstock J, Einhorn D, Hershon K, Glazer NB, Yu S (2002) Int J Clin Pract 56:251–257

    CAS  Google Scholar 

  16. Aronoff S, Rosenblatt S, Braithwaite S, Egan JW, Mathisen AL, Schneider RL (2000) Diabetes Care 23:1605–1611. doi:10.2337/diacare.23.11.1605

    Article  CAS  Google Scholar 

  17. Kipnes MS, Krosnick A, Rendell MS, Egan JW, Mathisen AL, Schneider RL (2001) Am J Med 111:10–17. doi:10.1016/S0002-9343(01)00713-6

    Article  CAS  Google Scholar 

  18. Einhorn D, Rendell M, Rosenzweig J, Egan JW, Mathisen AL, Schneider RL (2000) Clin Ther 22:1395–1409. doi:10.1016/S0149-2918(00)83039-8

    Article  CAS  Google Scholar 

  19. Matthews DR, Cull CA, Stratton IM, Holman RR, Turner RC (1998) Diabet Med 15:297–303. doi:10.1002/(SICI)1096-9136(199804)15:4<297::AID-DIA572>3.3.CO;2-N

    Article  CAS  Google Scholar 

  20. Kiayias JA, Vlachou ED, Theodosopoulou E, Lakka-Papadodima E (2002) Diabetes Care 25:1251–1252. doi:10.2337/diacare.25.7.1251

    Article  Google Scholar 

  21. Ramachandran A, Snehalatha C, Salini J, Vijay V (2004) J Assoc Physicians India 52:459–463

    CAS  Google Scholar 

  22. Dams R, Huestis MA, Lambert WE, Murphy CM (2003) J Am Soc Mass Spectrom 14:1290–1294. doi:10.1016/S1044-0305(03)00574-9

    Article  CAS  Google Scholar 

  23. Food and Drug Administration of the United States (2001) Guidance for Industry-Bioanalytical Method Validation, US Department of Health and Human Services, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM). http://www/fda.gov/cder/guidance/index.htm

  24. Jain D, Jain S, Jain D, Amin M (2008) J Chromatogr Sci 46:501–504

    CAS  Google Scholar 

  25. Wang M, Miksa IR (2007) J Chromatogr B 856:318–327. doi:10.1016/j.jchromb.2007.06.037

    Article  CAS  Google Scholar 

  26. Mistri HN, Jangid AG, Shrivastav PS (2007) J Pharm Biomed Anal 45(1):97–106. doi:10.1016/j.jpba.2007.06.003

    Article  CAS  Google Scholar 

Download references

Acknowledgments

One of the authors’ Pinaki Sengupta, is grateful to the Department of Science and Technology (DST), Govt. of India, New Delhi, for providing necessary instrumental facilities to carry out this work through their project No. VI/D&P/186/06-07/TDT under DPRP programme.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tapan Kumar Pal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sengupta, P., Bhaumik, U., Ghosh, A. et al. LC–MS–MS Development and Validation for Simultaneous Quantitation of Metformin, Glimepiride and Pioglitazone in Human Plasma and Its Application to a Bioequivalence Study. Chroma 69, 1243–1250 (2009). https://doi.org/10.1365/s10337-009-1056-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1365/s10337-009-1056-5

Keywords

Navigation